Fig. 4

TASL expression is potentially predictive of immunotherapy response. A Response/non-response rates to treatment for low and high TASL expression groups in each immunotherapy dataset. B Differences in TASL expression between responders (R) and non-responders (NR). C ROC curves were used to assess the ability of TASL expression to differentiate responders (R) from non-responders (NR). D-E K-M curves of OS or PFS between low and high TASL expression groups. F Scatter plot of TIL fractions (%) and TASL expression in GSE121810 for group NA-aPD1 (green) and group A-aPD1 (purple), R: Spearman’s correlation coefficient